Reactive lymphocytes in patients with COVID-19.
作者信息
Chong Vanessa C L, Lim Kian Guan Eric, Fan Bingwen Eugene, Chan Stephrene S W, Ong Kiat H, Kuperan Ponnudurai
机构信息
Tan Tock Seng Hospital, Singapore.
出版信息
Br J Haematol. 2020 Jun;189(5):844. doi: 10.1111/bjh.16690. Epub 2020 May 5.
Abstract
摘要
相似文献
1
Reactive lymphocytes in patients with COVID-19.新型冠状病毒肺炎患者中的反应性淋巴细胞
Br J Haematol. 2020 Jun;189(5):844. doi: 10.1111/bjh.16690. Epub 2020 May 5.
2
SARS-CoV-2: a new aetiology for atypical lymphocytes.严重急性呼吸综合征冠状病毒2型：非典型淋巴细胞的一种新病因。
Br J Haematol. 2020 Jun;189(5):845. doi: 10.1111/bjh.16730. Epub 2020 May 14.
3
Leukoerythroblastosis and plasmacytoid lymphocytes in a child with SARS-CoV-2-associated multisystem inflammatory syndrome.一名患有新型冠状病毒2型相关多系统炎症综合征儿童的白细胞红细胞增多症和浆细胞样淋巴细胞
Blood. 2020 Aug 13;136(7):914. doi: 10.1182/blood.2020007132.
4
Atypical lymphocytes in peripheral blood of patients with COVID-19.新型冠状病毒肺炎患者外周血中的异型淋巴细胞。
Br J Haematol. 2020 Jul;190(1):36-39. doi: 10.1111/bjh.16848. Epub 2020 Jun 2.
5
HMGB1: A Possible Crucial Therapeutic Target for COVID-19?高迁移率族蛋白B1：新冠病毒病一个可能的关键治疗靶点？
Horm Res Paediatr. 2020;93(2):73-75. doi: 10.1159/000508291. Epub 2020 May 6.
6
Neutrophil-to-Lymphocyte ratio as a potential biomarker for disease severity in COVID-19 patients.中性粒细胞与淋巴细胞比值可作为 COVID-19 患者疾病严重程度的潜在生物标志物。
J Glob Antimicrob Resist. 2020 Sep;22:862-863. doi: 10.1016/j.jgar.2020.07.029. Epub 2020 Aug 15.
7
Convalescent donor SARS-COV-2-specific cytotoxic T lymphocyte infusion as a possible treatment option for COVID-19 patients with severe disease has not received enough attention till date.恢复期供体的新冠病毒特异性细胞毒性T淋巴细胞输注作为重症COVID-19患者的一种可能治疗选择，迄今为止尚未得到足够关注。
Br J Haematol. 2020 Jun;189(6):1062-1063. doi: 10.1111/bjh.16780. Epub 2020 May 19.
8
A NET-thrombosis axis in COVID-19.新冠病毒肺炎中的一种神经内分泌血栓形成轴。
Blood. 2020 Sep 3;136(10):1118-1119. doi: 10.1182/blood.2020007951.
9
SARS-CoV-2 infection: The role of cytokines in COVID-19 disease.严重急性呼吸综合征冠状病毒 2 感染：细胞因子在 COVID-19 疾病中的作用。
Cytokine Growth Factor Rev. 2020 Aug;54:62-75. doi: 10.1016/j.cytogfr.2020.06.001. Epub 2020 Jun 2.
10
COVID-19 as a cause of immune thrombocytopenia.新型冠状病毒肺炎作为免疫性血小板减少症的一个病因
Med Mal Infect. 2020 Aug;50(5):459-460. doi: 10.1016/j.medmal.2020.05.003. Epub 2020 May 20.
引用本文的文献
1
The external validity of machine learning-based prediction scores from hematological parameters of COVID-19: A study using hospital records from Brazil, Italy, and Western Europe.基于新冠肺炎血液学参数的机器学习预测评分的外部有效性：一项使用巴西、意大利和西欧医院记录的研究。
PLoS One. 2025 Feb 4;20(2):e0316467. doi: 10.1371/journal.pone.0316467. eCollection 2025.
2
Serum Procalcitonin, Hematology Parameters, and Cell Morphology in Multiple Clinical Conditions and Sepsis.血清降钙素原、血液学参数和多种临床情况及脓毒症中的细胞形态学。
J Clin Lab Anal. 2024 Oct;38(19-20):e25100. doi: 10.1002/jcla.25100. Epub 2024 Sep 21.
3
Morphological abnormalities of leukocytes in SARS-CoV-2 infection.严重急性呼吸综合征冠状病毒 2 感染患者白细胞的形态学异常。
Afr Health Sci. 2023 Dec;23(4):102-107. doi: 10.4314/ahs.v23i4.13.
4
Morphological abnormalities of peripheral blood cells among patients with COVID-19 disease.新型冠状病毒肺炎患者外周血细胞的形态学异常
Heliyon. 2024 Jan 17;10(2):e24527. doi: 10.1016/j.heliyon.2024.e24527. eCollection 2024 Jan 30.
5
A multiple instance learning approach for detecting COVID-19 in peripheral blood smears.一种用于在外周血涂片检测新型冠状病毒肺炎的多实例学习方法。
PLOS Digit Health. 2022 Aug 19;1(8):e0000078. doi: 10.1371/journal.pdig.0000078. eCollection 2022 Aug.
6
Atypical lymphocytes in the peripheral blood of COVID-19 patients: A prognostic factor for the clinical course of COVID-19.COVID-19 患者外周血中的异型淋巴细胞：COVID-19 临床病程的预后因素。
PLoS One. 2021 Nov 12;16(11):e0259910. doi: 10.1371/journal.pone.0259910. eCollection 2021.
7
Changes in peripheral blood in SARS CoV-2 patients and its clinico-pathological correlation: A prospective cross-sectional study.SARS-CoV-2 患者外周血变化及其与临床病理的相关性：一项前瞻性横断面研究。
Int J Lab Hematol. 2021 Dec;43(6):1334-1340. doi: 10.1111/ijlh.13720. Epub 2021 Oct 1.
8
One Year on: An Overview of Singapore's Response to COVID-19-What We Did, How We Fared, How We Can Move Forward.一年回顾：新加坡应对 COVID-19 的概述——我们做了什么、表现如何、如何继续前进。
Int J Environ Res Public Health. 2021 Aug 30;18(17):9125. doi: 10.3390/ijerph18179125.
9
Implications of mRNA-based SARS-CoV-2 vaccination for cancer patients.mRNA 疫苗接种对癌症患者的影响。
J Immunother Cancer. 2021 Jun;9(6). doi: 10.1136/jitc-2021-002932.
10
Development of infectious mononucleosis as an unusual manifestation of COVID-19.
Auris Nasus Larynx. 2022 Dec;49(6):1067-1071. doi: 10.1016/j.anl.2021.04.005. Epub 2021 Apr 12.
本文引用的文献
1
Haematological parameters in severe acute respiratory syndrome.严重急性呼吸综合征中的血液学参数
Clin Lab Haematol. 2005 Feb;27(1):15-20. doi: 10.1111/j.1365-2257.2004.00652.x.
2
A major outbreak of severe acute respiratory syndrome in Hong Kong.香港爆发严重急性呼吸系统综合症。
N Engl J Med. 2003 May 15;348(20):1986-94. doi: 10.1056/NEJMoa030685. Epub 2003 Apr 7.
Zotero 插件